Mikhail Y Sinelnikov (Ksenia S Maslenkina, Ksenia Maslenkina, K S Maslenkina)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Signaling Pathway

Ulcerative Colitis

Cross Sectional

Top Venues

Cancer medicine

Arkhiv patologii

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Mikhail Y Sinelnikov, Eugeny Motilev, Michail Gushchin, R A Vandysheva, Liudmila M Mikhaleva
[Pathomorphological criteria and features of immune response in eosinophilic esophagitis and reflux esophagitis]. Arkhiv patologii 86 (1) (2024)
Mikhail Y Sinelnikov, Liudmila M Mikhaleva, Alexander Mikhalev, Valeria Kaibysheva, Dmitrii A Atiakshin, Eugeny Motilev, Igor B Buchwalow, Markus Tiemann
Assessment of the Severity and the Remission Criteria in Eosinophilic Esophagitis. Biomedicines 11 (12) (2023)
Mikhail Y Sinelnikov, Liudmila M Mikhaleva, Maxim Naumenko, Rositsa Vandysheva, Michail Gushchin, Dmitrii A Atiakshin, Igor B Buchwalow, Markus Tiemann
Signaling Pathways in the Pathogenesis of Barrett's Esophagus and Esophageal Adenocarcinoma. International journal of molecular sciences 24 (11) (2023)
Nikolay K Shakhpazyan, Liudmila M Mikhaleva, Arkady L Bedzhanyan, Nikolay K Sadykhov, Konstantin Y Midiber, Alexandra K Konyukova, Andrey S Kontorschikov, Mikhail Y Sinelnikov, Alexander N Orekhov
Long Non-Coding RNAs in Colorectal Cancer: Navigating the Intersections of Immunity, Intercellular Communication, and Therapeutic Potential. Biomedicines 11 (9) (2023)
Mikhail Y Sinelnikov, Liudmila M Mikhaleva, Alexander Mikhalev, Valeria Kaibysheva, Dmitrii A Atiakshin, Eugeny Motilev, Igor B Buchwalow, Markus Tiemann
Assessment of the Severity and the Remission Criteria in Eosinophilic Esophagitis. Biomedicines 11 (12) (2023)
Ksenia S Maslyonkina, Alexandra K Konyukova, Darya Y Alexeeva, Mikhail Y Sinelnikov, Liudmila M Mikhaleva
Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression. Cancer medicine (2021)